TenQ · fact sheet · filings current to · price as of
CVS Health (CVS)
The business itself is the question here - 18 of 36 checks passed.
Latest close : $96.74, -0.5% on the day; -12.0% from the 52-week high. Refreshed every trading night.
Full analysis: report · all charts. Financial statements are computed from SEC EDGAR XBRL filings, current to . The share price and everything built on it (market cap, multiples, yields, the Value and Trend checks) are refreshed every trading night; this page shows the close of . Not investment advice.
Key figures
| Share price (delayed close) | $96.74 |
| Market cap | $123.7B |
| 52-week range | $68.10 - $109.92 |
| P/E | 25.1x |
| P/E, own 10-year median | 13.8x |
| P/S | 0.3x |
| Free cash flow yield | 9.5% |
| Dividend yield | 2.7% |
| Revenue (TTM) | $415.1B |
| Net income (TTM) | $4.9B |
| Free cash flow (TTM) | $11.8B |
| Gross margin | 7.1% |
| Operating margin | 2.0% |
| Return on equity | 6.1% |
| Revenue growth (1y) | +7.4% |
| Revenue CAGR (3y) | +7.6% |
| Debt / equity | 0.75x |
| Cash & short-term investments | $14.0B |
| Shares outstanding | 1,279m (cover page of the latest filing, 2026-07-29) |
The score: 18 of 36 checks passed
Six chapters, six pass/fail checks each. Five are computed from the filings; Trend is price behaviour, and says so.
Is CVS stock cheap or expensive right now?
Value · 2 of 6 checks passed. Expensive against its own history and its sector - you're paying up for what you get. chapter →
Is CVS Health still growing?
Growth · 3 of 6 checks passed. Growing, but with caveats - revenue +7.4% over the last year. chapter →
Does CVS Health make real money?
Quality · 2 of 6 checks passed. Profitability is thin or negative - the growth isn't turning into money yet. chapter →
Can CVS Health survive a bad year?
Health · 2 of 6 checks passed. The balance sheet carries real risk - read the checks before anything else. chapter →
What does CVS Health hand back to shareholders?
Shareholder returns · 5 of 6 checks passed. Owners are paid reliably and affordably, and the share count is not eroding their stake. chapter →
Which way is CVS trending?
Trend analysis · 4 of 6 checks passed. Mixed signals from the market - some trends up, some rolling over. chapter →
Are insiders buying or selling CVS?
Open-market buys: $1,289 · sells: $324M, across the recent Form 4 filings. detail →
Other specialty retail we cover: Amazon (AMZN) · Ulta Beauty (ULTA) · Wayfair (W) · Chewy (CHWY) · every company →
Method: figures computed deterministically from SEC EDGAR XBRL (companyfacts, frames, financial-statement-and-notes datasets, Form 4); prices delayed end-of-day. Scores count transparent pass/fail checks. Missing data is shown as missing, never estimated. Last changed . © TenQ - cite with a link to this page.